Prisma Health is administering the monoclonal antibody treatments, Bamlanivimab and Regeneron, to high-risk COVID-19 patients in the Midlands and Upstate. Both drugs have not been approved but was authorized for emergency use by the Food and Drug Administration (FDA). The treatment can be used in patients who are 12 yearsContinue Reading
Prisma Health continues to provide innovative care for Heart Failure patients and is proud to lead the country in implementation of the CardioMEMS HF System, a wireless device that allows heart failure patients to monitor their pulmonary artery pressure from the comfort of their home. Since its initial launch atContinue Reading
Prisma Health Baptist Parkridge Hospital has earned the national distinction of being named a 2020 Leapfrog Top General Hospital. The Leapfrog Group annually recognizes hospitals achieving the highest standards of excellence in quality and safety by honoring them as a Top Hospital. Fewer than 6 percent of all eligible facilitiesContinue Reading
Prisma Health is now offering limited visitation for designated care partners as of, September 1. “Being with a loved one is, in itself, a healing therapy, and Prisma Health looks forward to offering expanded visitation for designated care partners next week,” said Scott Sasser, MD, a nationally recognized disaster preparednessContinue Reading